Okta Named a Leader in 2025 Gartner® Magic Quadrant™ for Access Management for Ninth Consecutive Year — Neutral
OKTA Business Wire — November 18, 2025SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (NASDAQ:OKTA), the leading independent identity partner, today announced that it has been recognized as a Leader in the 2025 Gartner Magic Quadrant for Access Management for the ninth consecutive year. A complimentary version of the full report can be found here. Gartner defines access management (AM) as tools that include authentication, authorization, single sign-on (SSO), and adaptive access capabilities for modern standards-based web applications,.
Keysight Introduces Scalable, Modular, All-in-One Testing Solution to Accelerate High-Volume PCBA Manufacturing — Neutral
KEYS Business Wire — November 18, 2025SANTA ROSA, Calif.--(BUSINESS WIRE)--Compact, modular system with integrated multi-test capability and up to 20-core parallel testing for high-volume efficiency.
Rockwell Automation to Build New Greenfield Manufacturing Site in Southeastern Wisconsin — Neutral
ROK Business Wire — November 18, 2025MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE:ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced plans to build a new greenfield manufacturing site in Southeastern Wisconsin. The project marks the next step in the company's previously announced $2 billion investment in plants, digital infrastructure, and talent to grow share, build resilience, and expand margins over the next five years. The facility has the potential t.
ALX Oncology to Present at Upcoming Investor Conferences — Neutral
ALXO GlobeNewsWire — November 18, 2025SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York.
EA SPORTS™ Announces Plans for Future EA SPORTS F1® Experiences, Including 2026 FIA Formula One World Championship™ Season Expansion & All-New F1 Game in 2027 — Neutral
EA Business Wire — November 18, 2025REDWOOD CITY, Calif.--(BUSINESS WIRE)--Electronic Arts Inc. (NASDAQ: EA) today confirmed plans for the future of the EA SPORTS™ F1® game series, the official games of the FIA Formula One World Championship™. Since launch, EA SPORTS™ F1® 25 has received praise from players, media, content creators, F1 drivers and more. Now looking forward, players in F1 25 will be able to expand their experience next year with the full 2026 FIA Formula One World Championship™. Coming in 2026 as a paid expansion*.
Proofpoint Satori™ Emerging Threats Intelligence Agent Now Generally Available for Microsoft Security Copilot — Neutral
MSFT Business Wire — November 18, 2025SUNNYVALE, Calif.--(BUSINESS WIRE)--Proofpoint, Inc., a leading cybersecurity and compliance company, today announced the general availability of its Proofpoint Satori™ Emerging Threats Intelligence Agent for Microsoft Security Copilot. “AI is the force multiplier for defenders, and when partners bring their agentic innovation into the Security Copilot ecosystem, the impact is exponential. Together, we're not just building tools—we're creating a new era of intelligent, collaborative cyber defen.
James Hardie Industries plc (JHX) Q2 2026 Earnings Call Transcript — Neutral
JHX Seeking Alpha — November 18, 2025James Hardie Industries plc ( JHX ) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Joe Ahlersmeyer - Vice President of Investor Relations Aaron Erter - CEO & Executive Director Jonathan Skelly - President – AZEK Residential Conference Call Participants Trevor Allinson - Wolfe Research, LLC Keith Hughes - Truist Securities, Inc., Research Division Lee Power - JPMorgan Chase & Co, Research Division Ryan Merkel - William Blair & Company L.L.C., Research Division Timothy Wojs - Robert W.
Gladstone Capital (GLAD) Q4 2025 Earnings Call Transcript — Neutral
GLAD Seeking Alpha — November 18, 2025Gladstone Capital ( GLAD ) Q4 2025 Earnings Call November 18, 2025 8:30 AM EST Company Participants David Gladstone - Chairman & CEO Catherine Gerkis - Director of Investor Relations & ESG Robert Marcotte - President Nicole Schaltenbrand - CFO & Treasurer Conference Call Participants Erik Zwick - Lucid Capital Markets, LLC, Research Division Christopher Nolan - Ladenburg Thalmann & Co. Inc., Research Division Robert Dodd - Raymond James & Associates, Inc., Research Division Presentation Operator Greetings, and welcome to the Gladstone Capital Corporation Fourth Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Anthropic to buy $30 billion in Azure capacity in new deal with Microsoft, Nvidia — Positive
MSFT NVDA CNBC Television — November 18, 2025Microsoft on Tuesday announced new strategic partnerships with Nvidia and the artificial intelligence startup Anthropic, the latest sign that the company is working to reduce its dependence on OpenAI.
Home Depot Stock Slides as Weak Demand Dings Earnings — Negative
HD Schaeffers Research — November 18, 2025Shares of blue chip Home Depot Inc (NYSE:HD) are off 3.9% to trade at $345.93, after the home improvement chain reported adjusted third-quarter earnings of $3.74 per share, which fell short of estimates.
Will U.S. Onshoring and Chip Megaprojects Drive Sterling's Growth? — Positive
STRL Zacks Investment Research — November 18, 2025STRL gains momentum as U.S. onshoring and chip megaprojects fuel demand for its mission-critical and expanding E-Infrastructure work.
Euroseas Ltd. (ESEA) Lags Q3 Earnings and Revenue Estimates — Negative
ESEA Zacks Investment Research — November 18, 2025Euroseas Ltd. (ESEA) came out with quarterly earnings of $4.23 per share, missing the Zacks Consensus Estimate of $4.4 per share.
Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade — Positive
MASI Zacks Investment Research — November 18, 2025The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
HireQuest (HQI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now — Positive
HQI Zacks Investment Research — November 18, 2025After losing some value lately, a hammer chart pattern has been formed for HireQuest (HQI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Hippo Holdings (HIPO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now — Positive
HIPO Zacks Investment Research — November 18, 2025Hippo Holdings (HIPO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know — Positive
JBIO Zacks Investment Research — November 18, 2025The mean of analysts' price targets for Jade Biosciences, Inc. (JBIO) points to a 52.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Think Valley National (VLY) Could Surge 29.05%: Read This Before Placing a Bet — Positive
VLY Zacks Investment Research — November 18, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Valley National (VLY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tvardi (TVRD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive
TVRD Zacks Investment Research — November 18, 2025Tvardi (TVRD) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Wall Street Analysts Think FinWise Bancorp (FINW) Could Surge 26.01%: Read This Before Placing a Bet — Positive
FINW Zacks Investment Research — November 18, 2025The mean of analysts' price targets for FinWise Bancorp (FINW) points to a 26% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade — Positive
BSX Zacks Investment Research — November 18, 2025The consensus price target hints at a 25.3% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.